Bridion

Chemical Namesugammadex
Dosage FormInjection (intravenous; 200 mg/2 mL, 500 mg/5 mL)
Drug ClassMiscellaneous
SystemNervous
CompanyOrganon Sub Merck
Approval Year2015

Indication

  • For the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults undergoing surgery.
Last updated on 1/12/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Bridion (sugammadex) Prescribing Information2018Merck Sharp & Dohme Corp., Whitehouse Station, NJ